Safety and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir and +/- ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3-6) Agarwal, K., Brown, R. S., Dumas, E. O., McCaughan, G. W., Samuel, D., Terrault, N., Brown, K. A., Mantry, P. S., Berenguer, M., Kwo, P. Y., O'leary, J., Charafeddine, M., Pilot-Matias, T. J., Shuster, D. L., Lu, W., Enejosa, J. V., Cohen, D. E., Marino, Z., Forns, X. ELSEVIER SCIENCE BV. 2017: S529–S530

View details for DOI 10.1016/S0168-8278(17)31461-7

View details for Web of Science ID 000401056601304